{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:55:07Z","timestamp":1788368107039,"version":"build-2803163510"},"reference-count":185,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>The growing coexistence of HIV infection and type 2 diabetes mellitus (T2DM) represents a major clinical challenge in the antiretroviral therapy (ART) era. Improved survival of people living with HIV (PLHIV) has unveiled an increasing burden of metabolic disorders, with T2DM emerging as a leading comorbidity linked to chronic inflammation, adipose dysfunction, hepatic steatosis, and gut\u2013liver axis disruption. Epidemiological evidence indicates that PLHIV develop diabetes at younger ages and with greater cardiometabolic complications than the general population. Among adolescents and young adults with perinatally acquired HIV, lifelong ART exposure and early-life immune activation accelerate insulin resistance and \u03b2-cell stress, predisposing to early-onset T2DM. Sex differences further modulate this risk, as women with HIV exhibit disproportionate weight gain, altered fat distribution, and heightened inflammatory responses under specific ART regimens. The convergence of immunometabolic imbalance, hormonal factors, and social determinants creates a distinct pathophysiological landscape demanding tailored prevention and management strategies. Novel incretin-based and amylin therapies hold promise to address both dysglycemia and obesity, though data in PLHIV remain limited. Recognizing diabetes as a central and multifactorial complication of HIV is crucial to optimize long-term care, reduce cardiovascular and hepatic comorbidities, and improve quality of life across the HIV lifespan.<\/jats:p>","DOI":"10.3389\/fendo.2026.1734023","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T05:22:19Z","timestamp":1770700939000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Type 2 diabetes in people living with HIV: epidemiology, mechanisms, sex differences and early-life determinants"],"prefix":"10.3389","volume":"17","author":[{"given":"Raquel","family":"Moreno-Lopez","sequence":"first","affiliation":[{"name":"Grupo de Infecciones en la Poblaci\u00f3n Pedi\u00e1trica, Health Research Institute Gregorio Mara\u00f1\u00f3n (IiSGM)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Lazaro-Martin","sequence":"additional","affiliation":[{"name":"Grupo de Infecciones en la Poblaci\u00f3n Pedi\u00e1trica, Health Research Institute Gregorio Mara\u00f1\u00f3n (IiSGM)","place":["Madrid, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"D\u00edez","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII)","place":["Madrid, Spain"]},{"name":"Unidad de Enfermedades Infecciosas\/VIH, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Navarro-Gomez","sequence":"additional","affiliation":[{"name":"Grupo de Infecciones en la Poblaci\u00f3n Pedi\u00e1trica, Health Research Institute Gregorio Mara\u00f1\u00f3n (IiSGM)","place":["Madrid, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII)","place":["Madrid, Spain"]},{"name":"Servicio de Pediatr\u00eda, Hospital General Universitario Gregorio Mara\u00f1\u00f3n","place":["Madrid, Spain"]},{"name":"Departamento de Pediatr\u00eda, Universidad Complutense de Madrid (UCM)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Tarancon-Diez","sequence":"additional","affiliation":[{"name":"Grupo de Infecciones en la Poblaci\u00f3n Pedi\u00e1trica, Health Research Institute Gregorio Mara\u00f1\u00f3n (IiSGM)","place":["Madrid, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(23)00028-0","article-title":"Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies","volume":"10","author":"Trickey","year":"2023","journal-title":"Lancet HIV"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae014","article-title":"Time trends in causes of death in people with HIV: insights from the swiss HIV cohort study","volume":"79","author":"Weber","year":"2024","journal-title":"Clin Infect Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003348","article-title":"Trends in diabetes incidence and associated risk factors among people with HIV in the current treatment era","volume":"36","author":"Spieler","year":"2022","journal-title":"AIDS"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18083926","article-title":"The relationship between HIV duration, insulin resistance and diabetes risk","volume":"18","author":"Tiozzo","year":"2021","journal-title":"IJERPH"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002930","article-title":"Implications of weight gain with newer anti-retrovirals: 10-year predictions of cardiovascular disease and diabetes","volume":"35","author":"McCann","year":"2021","journal-title":"AIDS"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/6916497","article-title":"Prevalence, risk factors, and pathophysiology of dysglycemia among people living with HIV in sub-saharan africa","volume":"2018","author":"Njuguna","year":"2018","journal-title":"J Diabetes Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz999","article-title":"Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials","volume":"71","author":"Sax","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1106881","article-title":"Altered lipid metabolites accelerate early dysfunction of T cells in HIV-infected rapid progressors by impairing mitochondrial function","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2017.0314","article-title":"Lower concentrations of circulating medium and long-chain acylcarnitines characterize insulin resistance in persons with HIV","volume":"34","author":"Bailin","year":"2018","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2013.00037","article-title":"Beta cell dysfunction and insulin resistance","volume":"4","author":"Cerf","year":"2013","journal-title":"Front Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-0396","article-title":"\u03b2-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment","volume":"37","author":"Halban","year":"2014","journal-title":"Diabetes Care"},{"key":"B13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13010201","article-title":"Incretin therapies for patients with type 2 diabetes and chronic kidney disease","volume":"13","author":"Alicic","year":"2023","journal-title":"JCM"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/genes16050578","article-title":"Gene\u2013diet interactions in diabetes mellitus: current insights and the potential of personalized nutrition","volume":"16","author":"Kapellou","year":"2025","journal-title":"Genes"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B17","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2337\/dc23-Sint","article-title":"Standards of medical care in diabetes\u20142023","volume":"46","year":"2023","journal-title":"Diabetes Care"},{"key":"B18","volume-title":"Classification of diabetes mellitus","year":"2024"},{"key":"B19","volume-title":"IDF diabetes atlas","year":"2025"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30249-9","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"7","author":"Kristensen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","article-title":"Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: A meta-analysis","volume":"6","author":"McGuire","year":"2021","journal-title":"JAMA Cardiol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1001\/jama.2024.0318","article-title":"Long-term outcomes of medical management vs bariatric surgery in type 2 diabetes","volume":"331","author":"Courcoulas","year":"2024","journal-title":"JAMA"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0442","article-title":"Globalization of diabetes","volume":"34","author":"Hu","year":"2011","journal-title":"Diabetes Care"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa938","article-title":"Casting a health equity lens on endocrinology and diabetes","volume":"106","author":"Golden","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.10.1179","article-title":"Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study","volume":"165","author":"Brown","year":"2005","journal-title":"Arch Intern Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/00126334-200303010-00009","article-title":"Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women","volume":"32","author":"Justman","year":"2003","journal-title":"JAIDS J Acquired Immune Deficiency Syndromes"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43909","article-title":"Exploring the relation between diabetes and HIV: A narrative review","volume":"15","author":"Kumar","year":"2023","journal-title":"Cureus"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000000815","article-title":"Incidence and risk factors for prediabetes and diabetes mellitus among HIV-infected adults on antiretroviral therapy: A systematic review and meta-analysis","volume":"29","author":"Nansseu","year":"2018","journal-title":"Epidemiology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1097\/QAD.0000000000001888","article-title":"Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis","volume":"32","author":"Patel","year":"2018","journal-title":"AIDS"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e000304","DOI":"10.1136\/bmjdrc-2016-000304","article-title":"Is diabetes prevalence higher among HIV-infected individuals compared with the general population? Evidence from MMP and NHANES 2009\u20132010","volume":"5","author":"Hernandez-Romieu","year":"2017","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0254079","DOI":"10.1371\/journal.pone.0254079","article-title":"Development of type 2 diabetes and insulin resistance in people with HIV infection: Prevalence, incidence and associated factors","volume":"16","author":"Bratt","year":"2021","journal-title":"PloS One"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2021.101608","article-title":"Incidence and associated factors of type 2 diabetes mellitus onset in the Brazilian HIV\/AIDS cohort study","volume":"25","author":"Cassenote","year":"2021","journal-title":"Braz J Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"12730","DOI":"10.1038\/s41598-023-39828-6","article-title":"Non-communicable disease comorbidities in HIV patients: diabetes, hypertension, heart disease, and obstructive sleep apnea as a neglected issue","volume":"13","author":"Hadavandsiri","year":"2023","journal-title":"Sci Rep"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae112","article-title":"Incidence of diabetes mellitus and associated factors in the era of antiretroviral drugs with a low metabolic toxicity profile","volume":"11","author":"Montes","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e26059","DOI":"10.1002\/jia2.26059","article-title":"Prevalence and influences of diabetes and prediabetes among adults living with HIV in Africa: a systematic review and meta-analysis","volume":"26","author":"Peer","year":"2023","journal-title":"J Int AIDS Soc"},{"key":"B38","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1186\/s12889-025-21780-x","article-title":"The prevalence of comorbidities and differences in noncommunicable diseases and nonrandom associations of comorbidities between HIV-infected and -uninfected individuals in Guangdong Province, China","volume":"25","author":"Ye","year":"2025","journal-title":"BMC Public Health"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1101\/2024.03.10.24304033","article-title":"Associations of HIV and prevalent type 2 diabetes mellitus in the context of obesity in South Africa","volume":"14","author":"Magodoro","year":"2024","journal-title":"Journal of Multimorbidity and Comorbidity"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e29162","DOI":"10.1097\/MD.0000000000029162","article-title":"Trends & predictors of non-AIDS comorbidities among people living with HIV and receiving antiretroviral therapy in Lebanon","volume":"101","author":"Abou Hassan","year":"2022","journal-title":"Medicine"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e048744","DOI":"10.1136\/bmjopen-2021-048744","article-title":"Incidence of diabetes mellitus among people living with and without HIV in British Columbia, Canada between 2001 and 2013: a longitudinal population-based cohort study","volume":"11","author":"Bratu","year":"2021","journal-title":"BMJ Open"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.13871","article-title":"Unmasking a silent killer: Prevalence of diagnosed and undiagnosed diabetes mellitus among people living with HIV in rural South Africa","volume":"28","author":"De Vries","year":"2023","journal-title":"Trop Med Int Health"},{"key":"B43","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1186\/s12879-023-08736-5","article-title":"Prevalence of obesity, hypertension and diabetes among people living with HIV in South Africa: a systematic review and meta-analysis","volume":"23","author":"Gizamba","year":"2023","journal-title":"BMC Infect Dis"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.4102\/phcfm.v14i1.3256","article-title":"Lifestyle determinants of diabetes mellitus amongst people living with HIV in the Eastern Cape province, South Africa","volume":"14","author":"Bam","year":"2022","journal-title":"Afr J Primary Health Care Family Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2021.1925212","article-title":"Prevalence and risk factors of type II diabetes mellitus among people living with HIV in Texas","volume":"34","author":"Buendia","year":"2022","journal-title":"AIDS Care"},{"key":"B46","doi-asserted-by":"publisher","first-page":"10877","DOI":"10.1038\/s41598-025-96076-6","article-title":"Diabetes mellitus among HIV patients on ART at Woldia comprehensive specialized hospital, Northeast Ethiopia","volume":"15","author":"Geteneh","year":"2025","journal-title":"Sci Rep"},{"key":"B47","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1186\/s12889-024-18265-8","article-title":"Diabetes mellitus and associated risk factors among HIV infected patients on HAART","volume":"24","author":"Kanyara","year":"2024","journal-title":"BMC Public Health"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1105254","article-title":"Dietary patterns and diabetes mellitus among people living with and without HIV: a cross-sectional study in Tanzania","volume":"10","author":"Malindisa","year":"2023","journal-title":"Front Nutr"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001722","article-title":"Body mass index and the risk of serious non-AIDS events and all-cause mortality in treated HIV-positive individuals: D:A:D cohort analysis","volume":"78","author":"Achhra","year":"2018","journal-title":"JAIDS J Acquired Immune Deficiency Syndromes"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001071","article-title":"Weight gain and incident diabetes among HIV-infected veterans initiating antiretroviral therapy compared with uninfected individuals","volume":"73","author":"Herrin","year":"2016","journal-title":"JAIDS J Acquired Immune Deficiency Syndromes"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003970","article-title":"Risk factors for progression from prediabetes to diabetes among older people with HIV","volume":"38","author":"Masters","year":"2024","journal-title":"AIDS"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2019.07.051","article-title":"The global magnitude of metabolic syndrome among antiretroviral therapy (ART) exposed and ART-na\u00efve adult HIV-infected patients in gedio-zone, southern Ethiopia: Comparative cross-sectional study, using the Adult Treatment Panel III criteria","volume":"13","author":"Bune","year":"2019","journal-title":"Diabetes Metab Syndrome: Clin Res Rev"},{"key":"B53","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1365-201X.2004.01383.x","article-title":"Cellular mechanisms of insulin resistance, lipodystrophy and atherosclerosis induced by HIV protease inhibitors","volume":"183","author":"Rudich","year":"2005","journal-title":"Acta Physiologica Scandinavica"},{"key":"B54","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1186\/s12879-022-07485-1","article-title":"Insulin resistance in people living with HIV is associated with exposure to thymidine analogues and\/or didanosine and prior immunodeficiency","volume":"22","author":"H\u00f8gh","year":"2022","journal-title":"BMC Infect Dis"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e44575","DOI":"10.1371\/journal.pone.0044575","article-title":"Risk of diabetes mellitus in persons with and without HIV: A danish nationwide population-based cohort study","volume":"7","author":"Rasmussen","year":"2012","journal-title":"PloS One"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)63513-1","article-title":"Protease inhibitor-associated hyperglycaemia","volume":"350","author":"Dub\u00e9","year":"1997","journal-title":"Lancet"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199815000-00001","article-title":"Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients","volume":"12","author":"Walli","year":"1998","journal-title":"AIDS"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200309050-00022","article-title":"Stavudine or indinavir-containing regimens are associated with an increased risk of diabetes mellitus in HIV-infected individuals","volume":"17","author":"Brambilla","year":"2003","journal-title":"AIDS"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002119","article-title":"Prior exposure to thymidine analogs and didanosine is associated with long-lasting alterations in adipose tissue distribution and cardiovascular risk factors","volume":"33","author":"Gelpi","year":"2019","journal-title":"AIDS"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1086\/518619","article-title":"Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the swiss HIV cohort study","volume":"45","author":"Ledergerber","year":"2007","journal-title":"Clin Infect Dis"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e2844","DOI":"10.1097\/MD.0000000000002844","article-title":"Risk factors for incident diabetes in a cohort taking first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy","volume":"95","author":"Karamchand","year":"2016","journal-title":"Medicine"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1075","article-title":"Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using international diabetes foundation and adult treatment panel III criteria","volume":"30","author":"Samaras","year":"2007","journal-title":"Diabetes Care"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.63809","article-title":"Prevalence of diabetes mellitus in people living with HIV in dammam, Saudi Arabia","volume":"16","author":"Alsaeed","year":"2024","journal-title":"Cureus"},{"key":"B64","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12981-023-00510-6","article-title":"Blood glucose trajectories and incidence of diabetes mellitus in Ugandan people living with HIV initiated on dolutegravir","volume":"20","author":"Mulindwa","year":"2023","journal-title":"AIDS Res Ther"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e25484","DOI":"10.1002\/jia2.25484","article-title":"Weight gain among treatment-na\u00efve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada","volume":"23","author":"Bourgi","year":"2020","journal-title":"J Intern AIDS Soc"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa177","article-title":"Risk factors for weight gain following switch to integrase inhibitor\u2013based antiretroviral therapy","volume":"71","author":"Lake","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101836","article-title":"Change in body weight and risk of hypertension after switching from efavirenz to dolutegravir in adults living with HIV: evidence from routine care in Johannesburg, South Africa","volume":"57","author":"Brennan","year":"2023","journal-title":"eClinicalMedicine"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1904340","article-title":"The NAMSAL ANRS 12313 study group. Dolutegravir-based or low-dose efavirenz\u2013based regimen for the treatment of HIV-1","volume":"381","year":"2019","journal-title":"N Engl J Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/frph.2023.1133556","article-title":"Risks of metabolic syndrome in the ADVANCE and NAMSAL trials","volume":"5","author":"Tovar Sanchez","year":"2023","journal-title":"Front Reprod Health"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(20)30241-1","article-title":"Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial","volume":"7","author":"Venter","year":"2020","journal-title":"Lancet HIV"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902824","article-title":"Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV","volume":"381","author":"Venter","year":"2019","journal-title":"N Engl J Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003954","article-title":"Association between switching to integrase strand transfer inhibitors and incident diabetes in people with HIV","volume":"38","author":"Hwang","year":"2024","journal-title":"AIDS"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac355","article-title":"Integrase strand transfer inhibitors are associated with incident diabetes mellitus in people with human immunodeficiency virus","volume":"75","author":"O\u2019Halloran","year":"2022","journal-title":"Clin Infect Dis"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1403","article-title":"Risk of incident diabetes mellitus, weight gain, and their relationships with integrase inhibitor\u2013based initial antiretroviral therapy among persons with human immunodeficiency virus in the United States and Canada","volume":"73","author":"Rebeiro","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.13698","article-title":"Increased incidence of diabetes in people living with HIV treated with first-line integrase strand transfer inhibitors: A French multicentre retrospective study","volume":"26","author":"Ursenbach","year":"2025","journal-title":"HIV Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(25)00105-5","article-title":"Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial","volume":"12","author":"Ryan","year":"2025","journal-title":"Lancet HIV"},{"key":"B77","doi-asserted-by":"publisher","first-page":"e0244067","DOI":"10.1371\/journal.pone.0244067","article-title":"The association between HIV tri-therapy with the development of Type-2 Diabetes Mellitus in a rural South African District: A case-control study","volume":"15","author":"Bam","year":"2020","journal-title":"PloS One"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae167","article-title":"Diagnosis and risk factors of prediabetes and diabetes in people living with human immunodeficiency virus: evaluation of clinical and microbiome parameters","volume":"230","author":"Bar Ziv","year":"2024","journal-title":"J Infect Dis"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.7326\/ANNALS-24-00944","article-title":"Diabetes risk factors in people with HIV receiving pitavastatin versus placebo for cardiovascular disease prevention: A randomized trial","volume":"177","author":"Fitch","year":"2024","journal-title":"Ann Intern Med"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-025-01653-4","article-title":"Disturbances in the gut microbiota potentially associated with metabolic syndrome among patients living with HIV-1 and on antiretroviral therapy at Bafoussam Regional Hospital, Cameroon","volume":"17","author":"Diesse","year":"2025","journal-title":"Diabetol Metab Syndr"},{"key":"B81","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s13105-019-00673-9","article-title":"Characterization of gut microbiota composition in HIV-infected patients with metabolic syndrome","volume":"75","author":"Villanueva-Mill\u00e1n","year":"2019","journal-title":"J Physiol Biochem"},{"key":"B82","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13073-024-01336-1","article-title":"Metabolic and inflammatory perturbation of diabetes associated gut dysbiosis in people living with and without HIV infection","volume":"16","author":"Luo","year":"2024","journal-title":"Genome Med"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3390\/v17070990","article-title":"Possible crosstalk and alterations in gut bacteriome and virome in HIV-1 infection and the associated comorbidities related to metabolic disorder","volume":"17","author":"Shrivastav","year":"2025","journal-title":"Viruses"},{"key":"B84","doi-asserted-by":"publisher","first-page":"6725","DOI":"10.1038\/s41598-018-25168-3","article-title":"Impact of HIV and type 2 diabetes on gut microbiota diversity, tryptophan catabolism and endothelial dysfunction","volume":"8","author":"Hoel","year":"2018","journal-title":"Sci Rep"},{"key":"B85","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s43856-025-01149-2","article-title":"Metabolomics for searching non-invasive biomarkers of metabolic dysfunction-associated steatotic liver disease in youth with vertical HIV","volume":"5","author":"Chafino","year":"2025","journal-title":"Commun Med"},{"key":"B86","doi-asserted-by":"publisher","first-page":"21936","DOI":"10.1038\/s41598-021-01334-y","article-title":"Plasma extracellular vesicles in people living with HIV and type 2 diabetes are related to microbial translocation and cardiovascular risk","volume":"11","author":"Vestad","year":"2021","journal-title":"Sci Rep"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa338","article-title":"Repurposing metformin in nondiabetic people with HIV: influence on weight and gut microbiota","volume":"7","author":"Isnard","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-020-00267-2","article-title":"Metformin effect on gut microbiota: insights for HIV-related inflammation","volume":"17","author":"Ouyang","year":"2020","journal-title":"AIDS Res Ther"},{"key":"B89","volume-title":"Fact sheet 2024 - Latest global and regional HIV statistics on the status of the AIDS epidemic","year":"2024"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000842","article-title":"A systematic review of the inclusion (or exclusion) of women in HIV research: from clinical studies of antiretrovirals and vaccines to cure strategies","volume":"71","author":"Curno","year":"2016","journal-title":"JAIDS J Acquired Immune Deficiency Syndromes"},{"key":"B91","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1097\/QAD.0000000000003478","article-title":"Struble K. Participation of HIV-1 infected treatment-naive females in clinical trials and sex differences in efficacy and safety outcomes","volume":"37","author":"Zhou","year":"2023","journal-title":"AIDS"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/126.2.310","article-title":"FOR THE MULTICENTER AIDS COHORT STUDY. THE MULTICENTER AIDS COHORT STUDY: RATIONALE, ORGANIZATION, AND SELECTED CHARACTERISTICS OF THE PARTICIPANTS","volume":"126","author":"Kaslow","year":"1987","journal-title":"Am J Epidemiol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.12.9.1013-1019.2005","article-title":"The women\u2019s interagency HIV study: an observational cohort brings clinical sciences to the bench","volume":"12","author":"Bacon","year":"2005","journal-title":"Clin Vaccine Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001443","article-title":"Demographics and natural history of HIV-1-infected spontaneous controllers of viremia","volume":"31","author":"Yang","year":"2017","journal-title":"AIDS"},{"key":"B95","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/QAD.0000000000002043","article-title":"Strong sex bias in elite control of paediatric HIV infection","volume":"33","author":"Vieira","year":"2019","journal-title":"AIDS"},{"key":"B96","doi-asserted-by":"publisher","first-page":"24691","DOI":"10.1038\/s41598-024-73870-2","article-title":"Torque teno virus: a potential marker of immune reconstitution in youths with vertically acquired HIV","volume":"14","author":"Tarancon-Diez","year":"2024","journal-title":"Sci Rep"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1042\/CS20160112","article-title":"Sex and gender differences in HIV-1 infection","volume":"130","author":"Griesbeck","year":"2016","journal-title":"Clin Sci"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab558","article-title":"Sex differences in non-AIDS comorbidities among people with human immunodeficiency virus","volume":"8","author":"Pond","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1928","article-title":"Incident non-AIDS comorbidity burden among women with or at risk for human immunodeficiency virus in the United States","volume":"73","author":"Collins","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002349","article-title":"Non-AIDS comorbidity burden differs by sex, race, and insurance type in aging adults in HIV care","volume":"33","author":"Palella","year":"2019","journal-title":"AIDS"},{"key":"B101","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s41043-024-00695-0","article-title":"Incidence of type 2 diabetes mellitus in persons living with HIV initiated on dolutegravir-based antiretroviral regimen in Ghana: an observational longitudinal study","volume":"43","author":"Lartey","year":"2024","journal-title":"J Health Popul Nutr"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1177\/09564624221129410","article-title":"The risk of hyperglycemia associated with use of dolutegravir among adults living with HIV in Kampala, Uganda: A case-control study","volume":"33","author":"Namara","year":"2022","journal-title":"Int J STD AIDS"},{"key":"B103","volume-title":"HIV and adolescent girls and young women \u2014 Thematic briefing note \u2014 2024 global AIDS update The Urgency of Now: AIDS at a Crossroads","year":"2024"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2017.6717","article-title":"HIV-infected women gain more weight than HIV-infected men following the initiation of antiretroviral therapy","volume":"27","author":"Bares","year":"2018","journal-title":"J Women\u2019s Health"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz407","article-title":"Greater weight gain in treatment-naive persons starting dolutegravir-based antiretroviral therapy","volume":"70","author":"Bourgi","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2021.0091","article-title":"Integrase inhibitor use associated with weight gain in women and incident diabetes mellitus","volume":"38","author":"Asundi","year":"2022","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae474","article-title":"Short and long-term body weight change following the switch to or the addition of integrase inhibitors in persons with HIV differs by sex","volume":"80","author":"Lahiri","year":"2025","journal-title":"Clin Infect Dis"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy201","article-title":"Changes in waist circumference in HIV-infected individuals initiating a raltegravir or protease inhibitor regimen: effects of sex and race","volume":"5","author":"Bhagwat","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab537","article-title":"Assessment of obesity and cardiometabolic status by integrase inhibitor use in REPRIEVE: A propensity-weighted analysis of a multinational primary cardiovascular prevention cohort of people with human immunodeficiency virus","volume":"8","author":"Kileel","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"B110","doi-asserted-by":"publisher","first-page":"e2327584","DOI":"10.1001\/jamanetworkopen.2023.27584","article-title":"Aging-Related Comorbidity Burden Among Women and Men With or At-Risk for HIV in the US, 2008-2019","volume":"6","author":"Collins","year":"2023","journal-title":"JAMA Netw Open"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003127","article-title":"Sex differences in type 2 diabetes mellitus prevalence among persons with HIV","volume":"36","author":"Birabaharan","year":"2022","journal-title":"AIDS"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.676979","article-title":"Association of HIV-1 infection and antiretroviral therapy with type 2 diabetes in the hispanic population of the rio grande valley, texas, USA","volume":"8","author":"Lopez-Alvarenga","year":"2021","journal-title":"Front Med"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000003380","article-title":"Association of androgen hormones, sex hormone\u2013binding globulin, and the menopausal transition with incident diabetes mellitus in women with and without HIV","volume":"95","author":"Abelman","year":"2024","journal-title":"JAIDS J Acquired Immune Deficiency Syndromes"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2017.02.003","article-title":"Metabolic syndrome in HIV-infected middle-aged women on antiretroviral therapy: prevalence and associated factors","volume":"21","author":"Akl","year":"2017","journal-title":"Braz J Infect Dis"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000944","article-title":"Menopause: an opportunity to optimize health and well being for people with HIV","volume":"20","author":"Tariq","year":"2025","journal-title":"Curr Opin HIV AIDS"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-020-0551-5","article-title":"Potential role of the melanocortin signaling system interference in the excess weight gain associated to some antiretroviral drugs in people living with HIV","volume":"44","author":"Domingo","year":"2020","journal-title":"Int J Obes"},{"key":"B117","doi-asserted-by":"publisher","first-page":"e0229617","DOI":"10.1371\/journal.pone.0229617","article-title":"Lack of an association between clinical INSTI-related body weight gain and direct interference with MC4 receptor (MC4R), a key central regulator of body weight","volume":"15","author":"McMahon","year":"2020","journal-title":"PloS One"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000616","article-title":"Weight gain and integrase inhibitors","volume":"33","author":"Eckard","year":"2020","journal-title":"Curr Opin Infect Dis"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa259","article-title":"The integrase inhibitors dolutegravir and raltegravir exert proadipogenic and profibrotic effects and induce insulin resistance in human\/simian adipose tissue and human adipocytes","volume":"71","author":"Gorwood","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B120","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1038\/s41467-019-10440-5","article-title":"Sex-specific association between gut microbiome and fat distribution","volume":"10","author":"Min","year":"2019","journal-title":"Nat Commun"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes\u20142020","volume":"43","year":"2020","journal-title":"Diabetes Care"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1045628","article-title":"Impaired fasting glucose levels among perinatally HIV-infected adolescents and youths in Dar es Salaam, Tanzania","volume":"13","author":"Nkinda","year":"2022","journal-title":"Front Endocrinol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-021-00574-x","article-title":"Cardiometabolic complications in youth with perinatally acquired HIV in the era of antiretroviral therapy","volume":"18","author":"Dirajlal-Fargo","year":"2021","journal-title":"Curr HIV\/AIDS Rep"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3182a9466a","article-title":"Subclinical atherosclerosis and markers of immune activation in HIV-infected children and adolescents: the caroVIH study","volume":"65","author":"Sainz","year":"2014","journal-title":"JAIDS J Acquired Immune Deficiency Syndromes"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001506","article-title":"Low bone mineral density in vertically HIV-infected children and adolescents: risk factors and the role of T-cell activation and senescence","volume":"36","author":"Jim\u00e9nez","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"B126","doi-asserted-by":"publisher","first-page":"e25403","DOI":"10.1097\/MD.0000000000025403","article-title":"Effects of perinatal HIV-infection on the cortical thickness and subcortical gray matter volumes in young adulthood","volume":"100","author":"Ruiz-Saez","year":"2021","journal-title":"Medicine"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003892","article-title":"Incidence of non-AIDS defining comorbidities among young adults with perinatally acquired HIV in North America","volume":"38","author":"Haw","year":"2024","journal-title":"AIDS"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003170","article-title":"Prevalence of nonalcoholic fatty liver disease using noninvasive techniques among children, adolescents, and youths living with HIV","volume":"36","author":"Carrasco","year":"2022","journal-title":"AIDS"},{"key":"B129","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1093\/jac\/dkab277","article-title":"Early antiretroviral therapy initiation effect on metabolic profile in vertically HIV-1-infected children","volume":"76","author":"Taranc\u00f3n-Diez","year":"2021","journal-title":"J Antimicrobial Chemotherapy"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.13570","article-title":"High prevalence of low high-density lipoprotein cholesterol and insulin resistance among children and adolescents living with HIV in Uganda: harbinger for metabolic syndrome","volume":"25","author":"Kisitu","year":"2024","journal-title":"HIV Med"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001394","article-title":"Adiponectin, leptin and inflammatory markers in HIV-associated metabolic syndrome in children and adolescents","volume":"36","author":"Espiau","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jama.2023.4063","article-title":"Diagnosis and management of prediabetes: A review","volume":"329","author":"Echouffo-Tcheugui","year":"2023","journal-title":"JAMA"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002922","article-title":"Risk for incident diabetes is greater in prediabetic men with HIV than without HIV","volume":"35","author":"Slama","year":"2021","journal-title":"AIDS"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000663","article-title":"Metabolic and renal adverse effects of antiretroviral therapy in HIV-infected children and adolescents","volume":"34","author":"Fortuny","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.893579","article-title":"Prevalence and risk factors for hepatic steatosis in children with perinatal HIV on early antiretroviral therapy compared to HIV-exposed uninfected and HIV-unexposed children","volume":"10","author":"Rose","year":"2022","journal-title":"Front Pediatr"},{"key":"B136","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12879-015-0853-8","article-title":"Lipid and glucose alterations in perinatally-acquired HIV-infected adolescents and young adults","volume":"15","author":"Bl\u00e1zquez","year":"2015","journal-title":"BMC Infect Dis"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-S013","article-title":"13. Children and adolescents: standards of medical care in diabetes\u20132020","volume":"43","year":"2020","journal-title":"Diabetes Care"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph21040457","article-title":"Patterns and predictors of HIV comorbidity among adolescents and young adults in South Africa","volume":"21","author":"Van Wyk","year":"2024","journal-title":"IJERPH"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed10100295","article-title":"From pediatric to adult HIV care: what works to keep adolescents engaged\u2014A systematic review of transition strategies","volume":"10","author":"Hung","year":"2025","journal-title":"TropicalMed"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.13595","article-title":"HIV and type 2 diabetes: An evolving story","volume":"25","author":"Daultrey","year":"2024","journal-title":"HIV Med"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1391","article-title":"Primary care guidance for persons with human immunodeficiency virus: 2020 update by the HIV medicine association of the infectious diseases society of america","volume":"73","author":"Thompson","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2012.03948.x","article-title":"Summary report from the human immunodeficiency virus and aging consensus project: treatment strategies for clinicians managing older individuals with the human immunodeficiency virus","volume":"60","year":"2012","journal-title":"J Am Geriatrics Soc"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1177\/193229680900300303","article-title":"Hemoglobin A1c point-of-care assays; A new world with a lot of consequences","volume":"3","author":"Lenters-Westra","year":"2009","journal-title":"J Diabetes Sci Technol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1177\/1932296816678263","article-title":"Impact of hbA1c testing at point of care on diabetes management","volume":"11","author":"Schnell","year":"2017","journal-title":"J Diabetes Sci Technol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-0177","article-title":"A1C underestimates glycemia in HIV infection","volume":"32","author":"Kim","year":"2009","journal-title":"Diabetes Care"},{"key":"B146","article-title":"Australian society for HIV, viral hepatitis and sexual health medicine (ASHM)","year":"2020","journal-title":"Aust HIV Manage Guidelines 2020"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003486","article-title":"Comparison of five different risk scores to predict incident type 2 diabetes in the Swiss HIV cohort study","volume":"37","author":"Blondet","year":"2023","journal-title":"AIDS"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-0633","article-title":"Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy","volume":"33","author":"Brown","year":"2010","journal-title":"Diabetes Care"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00036.2003","article-title":"Visceral adiposity, C-peptide levels, and low lipase activities predict HIV-dyslipidemia","volume":"285","author":"Yarasheski","year":"2003","journal-title":"Am J Physiology-Endocrinology Metab"},{"key":"B150","doi-asserted-by":"publisher","first-page":"dom.14785","DOI":"10.1111\/dom.14785","article-title":"C-peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective","volume":"24","author":"Maddaloni","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000354","article-title":"Interleukin-6, high sensitivity C-reactive protein, and the development of type 2 diabetes among HIV-positive patients taking antiretroviral therapy","volume":"67","author":"B\u00e9t\u00e9n\u00e9 A Dooko","year":"2014","journal-title":"JAIDS J Acquired Immune Deficiency Syndromes"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003137","article-title":"Circulating CD4+ TEMRA and CD4+ CD28\u2013 T cells and incident diabetes among persons with and without HIV","volume":"36","author":"Bailin","year":"2022","journal-title":"AIDS"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.4314\/ahs.v23i1.14","article-title":"Evaluation of some immune and inflammatory responses in diabetes and HIV co-morbidity","volume":"23","author":"Chinyelu Chukwuanukwu","year":"2023","journal-title":"Afr H Sci"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11071818","article-title":"Monocyte activation and ageing biomarkers in the development of cardiovascular ischaemic events or diabetes in people with HIV","volume":"11","author":"Bernardino","year":"2023","journal-title":"Microorganisms"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad433","article-title":"Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis with liver fibrosis as predictors of new-onset diabetes mellitus in people with HIV: A longitudinal cohort study","volume":"77","author":"Han","year":"2023","journal-title":"Clin Infect Dis"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2022.03.008","article-title":"Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside","volume":"247","author":"Grieco","year":"2022","journal-title":"Trans Res"},{"key":"B157","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11892-022-01449-0","article-title":"Metabolomics of type 1 and type 2 diabetes: insights into risk prediction and mechanisms","volume":"22","author":"Izundegui","year":"2022","journal-title":"Curr Diabetes Rep"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000004231","article-title":"Associations of fecal and blood microbiota-related metabolites with gut microbiota and type 2 diabetes in HIV infection","volume":"39","author":"Jia","year":"2025","journal-title":"AIDS"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmicr.2022.100143","article-title":"Association between gut microbiota and prediabetes in people living with HIV","volume":"3","author":"Jayanama","year":"2022","journal-title":"Curr Res Microbial Sci"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003272","article-title":"Elevated CD4+ T-cell glucose metabolism in HIV+ women with diabetes mellitus","volume":"36","author":"Butterfield","year":"2022","journal-title":"AIDS"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2019.0078","article-title":"Short communication: metformin reduces CD4 T cell exhaustion in HIV-infected adults on suppressive antiretroviral therapy","volume":"36","author":"Shikuma","year":"2020","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103270","article-title":"LILAC pilot study: Effects of metformin on mTOR activation and HIV reservoir persistence during antiretroviral therapy","volume":"65","author":"Planas","year":"2021","journal-title":"EBioMedicine"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/3080969","article-title":"Intestinal microbiota dysbiosis promotes mucosal barrier damage and immune injury in HIV-infected patients","volume":"2023","author":"Pan","year":"2023","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.09.044","article-title":"An integrated overview of HIV-1 latency","volume":"155","author":"Ruelas","year":"2013","journal-title":"Cell"},{"key":"B165","doi-asserted-by":"publisher","first-page":"831","DOI":"10.14336\/AD.2023.0705","article-title":"Metformin treatment leads to increased HIV transcription and gene expression through increased CREB phosphorylation and recruitment to the HIV LTR promoter","volume":"15","author":"Rezaei","year":"2024","journal-title":"Aging Dis"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2022.0129","article-title":"Association between metformin use and cognitive and physical function in persons with HIV and diabetes","volume":"39","author":"Masters","year":"2023","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.847778","article-title":"Efficacy of dulaglutide in a patient with type 2 diabetes, high cardiovascular risk, and HIV: A case report","volume":"13","author":"Dardano","year":"2022","journal-title":"Front Endocrinol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0021","article-title":"Liraglutide treatment in a patient with HIV and uncontrolled insulin-treated type 2 diabetes","volume":"35","author":"Diamant","year":"2012","journal-title":"Diabetes Care"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2011.04.003","article-title":"Exenatide improves weight loss insulin sensitivity and \u03b2-cell function following administration to a type 2 diabetic HIV patient on antiretroviral therapy","volume":"72","author":"Oriot","year":"2011","journal-title":"Annales d\u2019Endocrinologie"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.13587","article-title":"Are glucagon-like peptide 1 receptor agonists effective in decreasing body weight and body mass index in people living with diabetes and HIV","volume":"25","author":"Bottanelli","year":"2024","journal-title":"HIV Med"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(24)00150-5","article-title":"Once-weekly semaglutide in people with HIV-associated lipohypertrophy: a randomised, double-blind, placebo-controlled phase 2b single-centre clinical trial","volume":"12","author":"Eckard","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1071\/SH22070","article-title":"Under-utilisation of cardioprotective glucose-lowering medication in diabetics living with HIV","volume":"19","author":"Butale","year":"2022","journal-title":"Sex Health"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.3390\/children11030275","article-title":"Glucagon-like peptide-1 receptor agonists\u2014A potential new medication for pediatric metabolic-dysfunction-associated steatotic liver disease (MASLD)","volume":"11","author":"Choi","year":"2024","journal-title":"Children"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2407379","article-title":"Liraglutide for children 6 to <12 years of age with obesity \u2014 A randomized trial","volume":"392","author":"Fox","year":"2025","journal-title":"N Engl J Med"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2025.3243","article-title":"Efficacy and safety of GLP-1 RAs in children and adolescents with obesity or type 2 diabetes: A systematic review and meta-analysis","volume":"179","author":"Kotecha","year":"2025","journal-title":"JAMA Pediatr"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000003904","article-title":"Decreased hepatic steatosis in South African adolescents with perinatal HIV switching to dolutegravir-containing regimens","volume":"42","author":"Rose","year":"2023","journal-title":"Pediatr Infect Dis J"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.4102\/hsag.v29i0.2445","article-title":"Physical activity and diet for Type 2 Diabetes reduction among older people living with HIV in Harare","volume":"29","author":"Mhlanga","year":"2024","journal-title":"Health SA Gesondheid"},{"key":"B178","doi-asserted-by":"publisher","first-page":"e078036","DOI":"10.1136\/bmjopen-2023-078036","article-title":"Lived experiences of people living with HIV and hypertension or diabetes access to care in Ethiopia: a phenomenological study","volume":"14","author":"Badacho","year":"2024","journal-title":"BMJ Open"},{"key":"B179","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1186\/s12913-025-12949-6","article-title":"Lived experiences and expectations of people living with HIV and co-morbid diabetes regarding primary care services in Harare, Zimbabwe: Patient perspective on burden of disease","volume":"25","author":"Chireshe","year":"2025","journal-title":"BMC Health Serv Res"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-024-02261-3","article-title":"Diabetes mellitus and associated factors among HIV-positive patients at primary health care facilities in Harare, Zimbabwe: a descriptive cross-sectional study","volume":"25","author":"Chireshe","year":"2024","journal-title":"BMC Prim Care"},{"key":"B181","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1186\/s12889-025-21715-6","article-title":"Perceptions and management of diabetes and obesity among people living with HIV in C\u00f4te d\u2019Ivoire: a qualitative study","volume":"25","author":"Koffi","year":"2025","journal-title":"BMC Public Health"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1080\/25787489.2024.2411481","article-title":"A cascade of care for diabetes in people living with HIV in a tertiary care center in Mexico City","volume":"25","author":"Espejo-Ortiz","year":"2024","journal-title":"HIV Res Clin Pract"},{"key":"B183","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2147\/CIA.S37738","article-title":"Polypharmacy in the HIV-infected older adult population","volume":"2018","author":"Shah","year":"2013","journal-title":"CIA"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.20m02888","article-title":"Long-acting injectable antipsychotic medication plus customized adherence enhancement in poor adherence patients with bipolar disorder","volume":"23","author":"Sajatovic","year":"2021","journal-title":"Prim Care Companion CNS Disord"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000608","article-title":"Polypharmacy in HIV: recent insights and future directions","volume":"15","author":"Edelman","year":"2020","journal-title":"Curr Opin HIV AIDS"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1734023\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T05:22:21Z","timestamp":1770700941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1734023\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":185,"alternative-id":["10.3389\/fendo.2026.1734023"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1734023","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"article-number":"1734023"}}